HDFCCC Neurologic Oncology Program Retreat
Thursday, April 21 at 9:00 am
-
1:00 pm
Add to Calendar
2022-04-21 16:00:00
2022-04-21 20:00:00
HDFCCC Neurologic Oncology Program Retreat
AGENDA
09:00-09:30 AM
Breakfast
09:30-09:40 AM
Update of the Neuro-Oncology Program - Susan Chang
09:40-10:00 AM
Developing experimental models to study human microglia diversity and interactions with neural stem cells - Tomasz Nowakowski
10:00- 11:20 AM
Wolfe Meningioma Program
10:00-10:05 AM
Introduction - David Raleigh
10:05-10:35 AM
Meningioma stem cells and DNA methylation groups: Biologic drivers and therapeutic vulnerabilities - David Raleigh
10:35-10:55 AM
Meningioma imaging to predict risk, response, and survival - Javier Villaneuva Meyer
10:55-11:10 AM
A gene expression biomarker for predicting meningioma outcomes and benefit from radiation therapy - William Chen
11:10-11:20 AM
Moving from bench to bedside: Clinical trial development and implementation for meningioma - Nancy Ann Oberheim Bush
11:20-11:30 AM
Open discussion
11:30-01:00 PM
Lunch
---
This is a program retreat of the Neurologic Oncology Program of the UCSF Helen Diller Family Comprehensive Cancer Center. Program members, please RSVP to Sue Stevens (Sue.Stevens@ucsf.edu).
550 16th Street
Mission Hall, MH-2103
San Francisco, CA 94158
United States
View on Map
Helen Diller Family Comprehensive Cancer Center
Sue.Stevens@ucsf.edu
America/Los_Angeles
public
550 16th Street
Mission Hall, MH-2103
San Francisco, CA 94158
United States
View on Map
AGENDA
09:00-09:30 AM
Breakfast
09:30-09:40 AM
Update of the Neuro-Oncology Program - Susan Chang
09:40-10:00 AM
Developing experimental models to study human microglia diversity and interactions with neural stem cells - Tomasz Nowakowski
10:00- 11:20 AM
Wolfe Meningioma Program
10:00-10:05 AM
Introduction - David Raleigh
10:05-10:35 AM
Meningioma stem cells and DNA methylation groups: Biologic drivers and therapeutic vulnerabilities - David Raleigh
10:35-10:55 AM
Meningioma imaging to predict risk, response, and survival - Javier Villaneuva Meyer
10:55-11:10 AM
A gene expression biomarker for predicting meningioma outcomes and benefit from radiation therapy - William Chen
11:10-11:20 AM
Moving from bench to bedside: Clinical trial development and implementation for meningioma - Nancy Ann Oberheim Bush
11:20-11:30 AM
Open discussion
11:30-01:00 PM
Lunch
---
This is a program retreat of the Neurologic Oncology Program of the UCSF Helen Diller Family Comprehensive Cancer Center. Program members, please RSVP to Sue Stevens (Sue.Stevens@ucsf.edu).
